✓ Credit card payment restored — secure checkout via Privacy Shield

Restasis Eye Drops

Restasis (cyclosporine 0.05%) — Allergan twice-daily immunomodulator eye drop for chronic dry-eye disease. Increases tear production over 4-8 weeks of consistent use.

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per vial
30 Vial/s
US$3.00/vial
US$90.00
60 Vial/s
US$2.67/vial · save 11%
US$160.00
90 Vials/s
US$2.33/vial · save 22%
US$210.00
180 Vial/s BEST VALUE
US$2.00/vial · save 33%
US$360.00
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Restasis Eye Drops?

Restasis Eye Drops is cyclosporine 0.05% ophthalmic emulsion for chronic dry eye disease — particularly evaporative and aqueous-deficient dry eye. Used twice daily long-term. Onset is gradual: 4–8 weeks for symptom relief, full effect by 6 months. Burning on instillation is common and usually settles.

Why order from MedsBase? Sourced from a WHO-GMP certified manufacturer · Discreet packaging · Worldwide Shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Restasis Eye Drops is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy — if it has not arrived after 20 business days we reship at no extra cost. Backed by 1,400+ verified customer reviews.

What is Restasis Eye Drops?

Restasis Eye Drops is manufactured by Allergan and contains cyclosporine 0.05% as a sterile ophthalmic emulsion. Topical cyclosporine is a calcineurin inhibitor that addresses the immune-mediated inflammatory component of chronic dry eye disease — distinct from purely lubricating artificial tears.

How It Works

Cyclosporine binds intracellular cyclophilin and inhibits calcineurin in T-lymphocytes, blocking the transcription of IL-2 and downstream T-cell-mediated inflammation. In chronic dry eye, conjunctival and lacrimal-gland T-cell infiltration drives a self-perpetuating inflammatory cycle — cyclosporine breaks this cycle, reducing inflammatory cytokines and increasing tear production over weeks to months.

Indications

  • Moderate-to-severe chronic dry eye disease with inflammatory component
  • Sjögren’s syndrome–associated keratoconjunctivitis sicca
  • Post-LASIK chronic dry eye
  • Atopic keratoconjunctivitis (off-label)
  • Vernal keratoconjunctivitis (off-label)
  • Graft-versus-host disease ocular involvement

Dosing

1 drop in each eye twice daily, ideally 12 hours apart. Continue indefinitely — cyclosporine is a chronic-disease therapy, not a course. Many patients also use preservative-free artificial tears alongside, instilled 5+ minutes after cyclosporine.

Onset takes weeks — give it time. Unlike artificial tears or steroids, cyclosporine works gradually. Symptoms typically begin to improve at 4–8 weeks. Full effect on tear production is at 3–6 months. Many patients abandon therapy too early — set the expectation that benefits build over months.

Side Effects

Most common: burning or stinging on instillation (15–20% of patients in the first 1–2 weeks; usually settles). Tip: a brief course of low-potency steroid or steroid-NSAID at initiation reduces burning.

Less common: conjunctival hyperaemia, ocular discharge, foreign body sensation, blurred vision after instillation, eye pain.

Systemic: negligible from topical use. Unlike oral cyclosporine, topical formulation does not cause kidney impairment, hypertension, or systemic immunosuppression.

Warnings & Contraindications

  • Active ocular infection (bacterial, viral, fungal) — treat infection first
  • Hypersensitivity to cyclosporine
  • Pregnancy / breastfeeding — Category C; topical absorption minimal, discuss with prescriber
  • Contact lens wearers — instil 15 minutes before lens insertion

Storage

Store at 15–25°C. Single-use vials are preservative-free; multi-dose bottles contain preservative or are designed for filterless dispensing.

Frequently Asked Questions

How long until Restasis Eye Drops works?

First symptom relief at 4–8 weeks. Full effect on tear production by 3–6 months. Many patients abandon too early — give it time.

Why does Restasis Eye Drops burn?

About 15–20% of patients experience burning or stinging in the first 1–2 weeks. The cause is partly the formulation vehicle (oil-in-water emulsion). Most settle. A short course of mild topical steroid alongside the start can reduce the burn.

Can I use Restasis Eye Drops with artificial tears?

Yes — wait at least 5 minutes between cyclosporine and any other drop. Many patients use cyclosporine BID and lubricants 4 times daily.

What is dry eye disease really?

Chronic dry eye is a multifactorial inflammatory disease of the ocular surface. Mechanisms include reduced tear production (aqueous-deficient), excessive evaporation (evaporative — usually meibomian gland dysfunction), and a self-sustaining inflammatory cycle. Cyclosporine targets the inflammatory cycle.

Will Restasis Eye Drops cause my immune system to weaken?

No — topical cyclosporine has minimal systemic absorption. The systemic side effects of oral cyclosporine (kidney impairment, hypertension, systemic infection risk) do not occur with eye-drop dosing.

Can Restasis Eye Drops be used with contact lenses?

Yes — instill 15 minutes before lens insertion. Some formulations are preservative-free single-use vials suitable for direct instillation with lenses in.

What if I miss a dose?

Take it as soon as you remember. Skipping occasional doses is fine; the effect builds over weeks.

Is Restasis Eye Drops safe in pregnancy?

Topical absorption is minimal, but pregnancy data are limited. Discuss with your prescriber.

What if cyclosporine alone isn't enough?

Many patients benefit from punctal plugs (small inserts that block tear drainage), warm compresses for meibomian gland dysfunction, omega-3 supplementation, and sometimes lifitegrast (Xiidra) as an alternative anti-inflammatory.

What about Restasis vs Cequa vs Klarity-C vs Restasis Eye Drops?

All are topical cyclosporine for dry eye. Restasis (Allergan) is 0.05% emulsion BID. Cequa (Sun) is 0.09% solution BID — newer, less burning. Klarity-C (Imprimis) is compounded variations. The active drug is the same; formulation differences affect tolerability.

Other Eye-Care Medications

Customers viewing this product also consider these alternatives in our Eye Care range:

Medical Disclaimer

The information on this page is for educational purposes only and is not a substitute for medical advice from a qualified ophthalmologist or optometrist. Eye conditions can rapidly threaten sight — sudden vision loss, severe pain, or trauma is an ophthalmology emergency. Always consult an eye-care professional before starting, stopping, or changing any treatment.

More options in Eye Care

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

0.05% / 0.4 ml

Quantity

30 Vial/s, 60 Vial/s, 90 Vials/s, 180 Vial/s

Reviews

There are no reviews yet

Add a review
Restasis Eye Drops Restasis Eye Drops
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Restasis Eye Drops Restasis Eye Drops
Your question
* Question is required
Name
* Name is required
There are no questions yet